CHARGE DENSITY STUDY OF AN ANTITHROMBOTIC DRUG - NEW ASPECTS IN DRUG DESIGN.

被引：0

作者：

Flaig, R. ^{[1
]}

Luger, P. ^{[1
]}

Soyka, R. ^{[2
]}

Koritsanszky, T. ^{[3
]}

机构：

[1] Free Univ Berlin, Inst Kristallog, Takustr 6, D-14195 Berlin, Germany

[2] Boehringer Ingelheim Pharma KG, Biberach, Germany

[3] Univ Witwatersrand, Dept Chem, Private Bag 3, ZA-2050 Johannesburg, South Africa

来源：

ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES | 1999年 / 55卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

P06.13.012

引用

页码：516 / 516

页数：1

共 50 条

[1] Antithrombotic drug design
Matsuno, H
CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (07) : 839 - 839
[2] New reagents, reactions, and peptidomimetics for drug design.
Goodman, M
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 222 : U75 - U76
[3] Chirality and drug design.
Anderson, PS
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 213 : 285 - MEDI
[4] CHARGE DENSITY STUDIES AS A TOOL IN DRUG DESIGN
Hibbs, D. E.
Hambley, T. W.
Johnston, G. A. R.
Hanrahan, J. R.
ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2002, 58 : C36 - C36
[5] Peptide deformaylase: New target for antibacterial drug design.
Pei, DH
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U212 - U212
[6] Issues of solvation in drug design.
Stouch, TR
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U474 - U474
[7] The importance of metabolism in drug design.
Pereira, Darcio Gomes
QUIMICA NOVA, 2007, 30 (01): : 171 - 177
[8] The latentiation process in drug design.
Chin, CM
Ferreira, EI
QUIMICA NOVA, 1999, 22 (01): : 75 - 84
[9] Molecular connectivity and drug design.
Galvez, J
Garcia-Domenech, R
de Julián-Ortiz, JV
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 220 : U284 - U284
[10] Bioavailability consideration in drug design.
Baldwin, JJ
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U459 - U459